Pendal Group LTD Quest Diagnostics Inc Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Pendal Group LTD holds 2,001 shares of DGX stock, worth $274,317. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,001

Holding current value

$274,317

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$123.31 - $157.26 $246,743 - $314,677	2,001 New	2,001 $0
Q2 2022 Jul 25, 2022	SELL	$127.07 - $145.39 $669,913 - $766,496	-5,272 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$129.09 - $164.35 $680,562 - $866,453	5,272 New	5,272 $722,000
Q2 2021 Jul 28, 2021	SELL	$126.66 - $141.48 $1.04 Million - $1.16 Million	-8,177 Closed	0 $0
Q1 2021 May 24, 2021	BUY	$114.63 - $133.34 $937,329 - $1.09 Million	8,177 New	8,177 $1.05 Million
Q1 2021 May 03, 2021	SELL	$114.63 - $133.34 $1.03 Million - $1.2 Million	-8,993 Closed	0 $0
Q4 2020 Jan 21, 2021	BUY	$112.7 - $128.05 $1.01 Million - $1.15 Million	8,993 New	8,993 $1.07 Million
Q3 2017 Nov 01, 2017	SELL	$91.96 - $108.35 $3.12 Million - $3.67 Million	-33,883 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	33,883	33,883 $0

Others Institutions Holding DGX

# of Institutions

909

Shares Held

96.1M

Call Options Held

587K

Put Options Held

235K

Vanguard Group Inc Valley Forge, PA

14M
Shares

$1.91 Billion
0.04% of portfolio
Black Rock Inc. New York, NY

10.1M
Shares

$1.38 Billion
0.03% of portfolio
State Street Corp Boston, MA

5.19M
Shares

$712 Million
0.03% of portfolio
Victory Capital Management Inc

3.88M
Shares

$532 Million
0.55% of portfolio
American Century Companies Inc Kansas City, MO

2.85M
Shares

$391 Million
0.24% of portfolio

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account